{"ticker": {"uuid": "8b826a61-db4b-4f70-bd06-0bce388a02fd", "symbol": "AARTIDRUGS", "name": "Aarti Drugs Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Aarti Drugs promoter group encumbers 12.39 lakh shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPbUdETHFuLVJTYjdDYVg3b2FpdVU1dHNkSWdQR2ExX1VTMmNkNGhmM2wzS1R0dlJNeUJxclhsTHF2bW5MZ3Y1UGQyQ19uaHJ4UUswQlFfMlVjYUxfd0lzMjJIdGFxMnFuWU9zMk1NN0I1NnFlbmdFNS1kb284VEdNN1RaRm9iRGY0WDhwb0lVQUJtUEhmOGRNU2JtRGlTalRYTE04Y0FMaHhncDItTWlyWXgydVB2MXpLRFZsUlJVaDU5dzA1OVE?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs to hold analyst meet on June 23 in Tarapur", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQc2VEMVVEMF9aWlBIaHlOaDFfNktKZnJ5SjQySVMwU2VJY3VfeERsUW40MFVNRVlBOFA3eXZlYUFqM241WkVEcDBpVmlIY2VJdzFsZTlBekJRTk5BMmJBOWI4b3VCTHlHak5QMWlOZGtVOHRaY0FxZC0xSGgyaU1nbkxGS1pFbzhHZ1dkNFBQanZvaURvRHpvVUlyZk9sZWdzRmFWcEE4bFV6VmoxblpCdw?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Q4 PAT Rises 36% QoQ to INR55.3 Crores", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQYUxvNmRQVGhaQWdOOGktVS1mWlVRaE1pelVLR2pPOTRqUjQ0WWM0cklNOXZEMXpwM0pNMVd3YjdoNU9XTUg4WnVlN3gzdTJHS0t6UVlhdEo1MDc3ekpWeE42czBVdnNkSE9tSDlOYVBUVUNGNXV0TTJKRXdKVmtMSnVvSjYzdGMzV2tjV1NkWlkxUEFab2VWU0NNLWN0T292V0hEY0J0Y1NFT1lXcDJYQ1ktSWRNTXh0dzA5SUxDcDdrcklYbXc?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Limited Just Recorded A 6.8% EPS Beat: Here's What Analysts Are Forecasting Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Limited Submits SEBI Compliance Certificate for Q4 FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNU3Rlb016d2YwbXJuVTBHaHRlLVZGT3JEaUwzVHhqUVJfemVIZjJqNHB1MjJkRzlqZFR1T2Rab08xWnEzdjdaUXVIRmxxaDFPNUJCeVV4b1V5c29lVXN2YmhxUVRUM1VZeFJfSW5jY3AtOGI5X0MtLXY2Mk9RbUhyLUlDR015ZmMtVlk1RGxiY0F2UXNZVGc2RjYtMzNPRnVncWlvQW93REhqRW5md3oydEVLZFczaENRalZmUmNrcUdKZw?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Limited Receives Credit Rating Reaffirmation from ICRA for Rs. 1,452.80 Crore Facilities", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRG5LSnhxOFFOZTNWMTJfZDRvajBUUk9QOV9MalloWkFyNS1CWFFCSENOUE5kS1Y3QVlkZlZXNlprNC1MaDJrVzhzWmtEV05neUlRVUJ2MVdnX3VXYmhyRGZVWkpOXzlUQmV3TE50MUVsYjFJV1RFWTI5b2tYRDNYQWtPNjJUSjZzd2hTaE5xdW1ySFRsWktJUHJHdFUtSmdOTVlKM1QxLWhIaXZRMTJJOXdodmJEUXVzM0V6cENTNWtaaU9iT0J4em5JOUZCdVRicVd2bTVBMFlPRDZORTBURFRraG1OYTBQa3hEZQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Faces Supreme Court Challenge as GST Department Appeals High Court Victory", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNbV9MVTd6S0xiaElXSEU5LTg1NGszUWl5cGpqTWpLMndXdUo0SU5YS3RaVl93Nmx2TjJXdEpvYnlzUW5tWnlJVlc5NDVpUzR4RXFqRDdEUEpDSFUxUWtZYUEtdGJCZW5UNUpVeXd6V3I4ZzFOeUlRWS1pWVJSTHl1UHIzQUhaTGxmYU1yeHJ5WTNoanNxd1NwNlZXaTBtdV9yMEdOX29iZGhLUHFKcDdSYmJpU0d5VlBZa01kOU85VW53V0dYX1p6NnVVb1NVOXM4WTdIMENCQ3cyTGs?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Sets February 9, 2026 Record Date for \u20b92 Interim Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOS1VVU0h5XzdFbzFZcVNrX0dmR3lwS1pOQks4RlhoSUFPYkYzOVVrcnBEZDVmdGZ4X0dodC1reEl2YXZzbWxLdU9vOERhZENEWkkxa1dKR2VZaWwzWWt0WTVMMDVGUU80T0Zud3dqTXBkcklKd0VhQ1RTUGw5ZXJuUGtqRnJFMTZfZlY1Qkt3YkIzdUdMMTE1c0VvTkxrWUJ2OWNTWVg0ZExlWmw3U0hOeEFDWTFIdHRv?oc=5", "source_name": "scanx.trade", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Q3 net profit, revenue up but margins falter; declares \u20b92 interim dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Limited Schedules Board Meeting for February 3, 2026 to Review Q3FY26 Results and Consider Interim Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdWlIQWZTLWF5UUJ4X0FjaWF5V3RlLUNzemVzOTRYUHVtQzhQTDZqSUt6Rm52dndLVzdneEhDeFpsQy14YkloUEJScy1SZlBXcXBDRGVUZTMzZk5ibU53M2FuOExidm1yeFlJc2d3T1Z3ekFGUGRydTZZYjF6Z0RVd01qdHZ6bW1uT2tfNkw4UVpLc1JfSDdURHNfSW5kaWc0d01kOEVGYWhUSVcybXF4b0ltVWdVcHhQUS1CblV1YWs0MzhoYkQtRUZKMHB1QktmaTdxQ1JHeVFjSmxpOThMT3NMWTYtcFUyMXoza0h5VTZEcGtONk80S2ZlTVhtRkRPcVA1MQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Ltd. Share Price Today - Aarti Drugs Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE9wMW5ORF9jT2tTVXgzaWNsaDNHemxINmpGYmVyZktxR1Qxc2lvS2xxdTNtdWRDSjVBQndoU2gyU01NaUVReG10amxORGpWLXFDMTRiV1J1aDJSV1R2d0o2OFhNV1p5a3JvcTluTDFrdXh0dlRHYVZOVEV3?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-02T10:51:34+00:00", "published_display": "02 Jan 2026 10:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Don't See Light At End Of Aarti Drugs Limited's (NSE:AARTIDRUGS) Tunnel And Push Stock Down 25%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-11T08:00:00+00:00", "published_display": "11 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Reports 9% Revenue Growth to \u20b9653Cr with Improved Margins in Q2FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOV2FHdjJ0UEJQOEJETkF1Q1BBdU1aenNqN0N3dkVjZEtkWXcweXU3OW1tX1pkdzNrS3BBSlZWQ0hud3RCdkZreWNiZHpwZFVsSkVEVVlaS2RFb2FpTVoxaW9UXzYzNUFuYW8wWGZEVlNUeFRpb0dHc0syUXdGa2RGdExkNjUxTXJDOEhsT29VazVnV2tWZDk4Ynl3bXlnRXJHdDF5UTNIbThMNHNUOHo2NkZVUjNYVTNxYmNfTDUwYS1kcHFfV1l4SXlB?oc=5", "source_name": "scanx.trade", "published_at": "2025-11-07T08:00:00+00:00", "published_display": "07 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs (NSE:AARTIDRUGS) Has A Pretty Healthy Balance Sheet", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPblZNbnFEbkdUUjRITEVuWU0tcVU2WEFqUnlmZUVseFRnYWQ5WVpTOFRfLUtFXzNOT2cwV2gySm13SzJLQ0tOcFdqNUZrS1BCQk5ZR1ZFUGlyTnJRUjhxdG5USzRhRlN3TGNXWU5IaHh3dVpXTFNWd2ItTnpaTHkweUFVNnNySjFIS3piRzg1aVJSSkZpM1ROeVFNNEJSWlAtbXpuSDJZaWp0OVdHV2hpdlRzaThGeWxGWkNzWVRZbjhmN2M5NktOd2RoZ2Q2YjVTRGFpek52YVRGWE1xRUlsN2xwNUo0eEljdnFj0gHwAUFVX3lxTFBIa3JRQXozdXVVWXlSeUVEVjZUR1Rpa0p5UlJXU0JMbWlzUFV1QUxMMXF6QW9fUzFQbmcwSkp6eDRkRnpoWHJPLWVxWWJwbEQ1QXJQZl9aSE84WFk3dEkyYlZFMnh4TkpQVk0zRTVyeGtXTzhiODA1X2w3dUhBLWhraFpURGlabE9TSlZZRDNtQXlpUTc1T004RFNyVkhFNHRBYkpfMEwySmZhQVoxcW16X0NyNkhzaFNYUl96bUozdWRoaElOUGI1dTl1bXN3RUx6ZkFHdG5QUE5MNnJSWFRzbGRmYkk4b1dJdHdtdDB2Ug?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-06T07:00:00+00:00", "published_display": "06 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy Aarti Drugs Ltd For Target Rs.610 Axis Securities Ltd", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSm9IQlNNNjFncWZtaTV3SS1MMW5ITXpnY2NtcUZycDdmcHZqWTJpek10VFBhZ2daZEY4SVVpV2FOQm00TWlBS2VFRGxuZ091X1JhcnItWktfcXhVYlVaZUFZQy1rS0ZLa3pPek5uTWNkRDVqcHg3czYwZmdmZUNXSm9PRTZ0S0FrOGdmZEN5bnZqUzlNX3NLZ09fNHRvbGFoWmxWNHFBLURRQQ?oc=5", "source_name": "Investment Guru India", "published_at": "2025-07-24T07:00:00+00:00", "published_display": "24 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Prakash Patil Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO is the most bullish insider, and their stock value gained 12%last week", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-16T07:00:00+00:00", "published_display": "16 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4FY25 earnings impact: Aarti Drugs shares up 14% on profit growth, MGL and KEI shares higher up to 4%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2025-05-07T07:00:00+00:00", "published_display": "07 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Ltd. Share Price Today | Aarti Drugs Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1sclltb2Q5aXYyNVJOam1uODZVeHFtNnUtRExtY042a1JFSlFrRnJHYjhDWi0xSDBYZWRhYndDYnJDMG1WZ2w3TVpfWjRHUi1KUkt2OXdlSDg5XzE5aVlLZVNZQXBJU2lVTTJaNTFCekhlVmc?oc=5", "source_name": "Value Research", "published_at": "2022-03-25T11:02:47+00:00", "published_display": "25 Mar 2022 11:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Aarti Drugs promoter group encumbers 12.39 lakh shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPbUdETHFuLVJTYjdDYVg3b2FpdVU1dHNkSWdQR2ExX1VTMmNkNGhmM2wzS1R0dlJNeUJxclhsTHF2bW5MZ3Y1UGQyQ19uaHJ4UUswQlFfMlVjYUxfd0lzMjJIdGFxMnFuWU9zMk1NN0I1NnFlbmdFNS1kb284VEdNN1RaRm9iRGY0WDhwb0lVQUJtUEhmOGRNU2JtRGlTalRYTE04Y0FMaHhncDItTWlyWXgydVB2MXpLRFZsUlJVaDU5dzA1OVE?oc=5", "source_name": "scanx.trade", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs to hold analyst meet on June 23 in Tarapur", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQc2VEMVVEMF9aWlBIaHlOaDFfNktKZnJ5SjQySVMwU2VJY3VfeERsUW40MFVNRVlBOFA3eXZlYUFqM241WkVEcDBpVmlIY2VJdzFsZTlBekJRTk5BMmJBOWI4b3VCTHlHak5QMWlOZGtVOHRaY0FxZC0xSGgyaU1nbkxGS1pFbzhHZ1dkNFBQanZvaURvRHpvVUlyZk9sZWdzRmFWcEE4bFV6VmoxblpCdw?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Q4 PAT Rises 36% QoQ to INR55.3 Crores", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQYUxvNmRQVGhaQWdOOGktVS1mWlVRaE1pelVLR2pPOTRqUjQ0WWM0cklNOXZEMXpwM0pNMVd3YjdoNU9XTUg4WnVlN3gzdTJHS0t6UVlhdEo1MDc3ekpWeE42czBVdnNkSE9tSDlOYVBUVUNGNXV0TTJKRXdKVmtMSnVvSjYzdGMzV2tjV1NkWlkxUEFab2VWU0NNLWN0T292V0hEY0J0Y1NFT1lXcDJYQ1ktSWRNTXh0dzA5SUxDcDdrcklYbXc?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Limited Just Recorded A 6.8% EPS Beat: Here's What Analysts Are Forecasting Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Limited Submits SEBI Compliance Certificate for Q4 FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNU3Rlb016d2YwbXJuVTBHaHRlLVZGT3JEaUwzVHhqUVJfemVIZjJqNHB1MjJkRzlqZFR1T2Rab08xWnEzdjdaUXVIRmxxaDFPNUJCeVV4b1V5c29lVXN2YmhxUVRUM1VZeFJfSW5jY3AtOGI5X0MtLXY2Mk9RbUhyLUlDR015ZmMtVlk1RGxiY0F2UXNZVGc2RjYtMzNPRnVncWlvQW93REhqRW5md3oydEVLZFczaENRalZmUmNrcUdKZw?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Limited Receives Credit Rating Reaffirmation from ICRA for Rs. 1,452.80 Crore Facilities", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRG5LSnhxOFFOZTNWMTJfZDRvajBUUk9QOV9MalloWkFyNS1CWFFCSENOUE5kS1Y3QVlkZlZXNlprNC1MaDJrVzhzWmtEV05neUlRVUJ2MVdnX3VXYmhyRGZVWkpOXzlUQmV3TE50MUVsYjFJV1RFWTI5b2tYRDNYQWtPNjJUSjZzd2hTaE5xdW1ySFRsWktJUHJHdFUtSmdOTVlKM1QxLWhIaXZRMTJJOXdodmJEUXVzM0V6cENTNWtaaU9iT0J4em5JOUZCdVRicVd2bTVBMFlPRDZORTBURFRraG1OYTBQa3hEZQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Faces Supreme Court Challenge as GST Department Appeals High Court Victory", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNbV9MVTd6S0xiaElXSEU5LTg1NGszUWl5cGpqTWpLMndXdUo0SU5YS3RaVl93Nmx2TjJXdEpvYnlzUW5tWnlJVlc5NDVpUzR4RXFqRDdEUEpDSFUxUWtZYUEtdGJCZW5UNUpVeXd6V3I4ZzFOeUlRWS1pWVJSTHl1UHIzQUhaTGxmYU1yeHJ5WTNoanNxd1NwNlZXaTBtdV9yMEdOX29iZGhLUHFKcDdSYmJpU0d5VlBZa01kOU85VW53V0dYX1p6NnVVb1NVOXM4WTdIMENCQ3cyTGs?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Sets February 9, 2026 Record Date for \u20b92 Interim Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOS1VVU0h5XzdFbzFZcVNrX0dmR3lwS1pOQks4RlhoSUFPYkYzOVVrcnBEZDVmdGZ4X0dodC1reEl2YXZzbWxLdU9vOERhZENEWkkxa1dKR2VZaWwzWWt0WTVMMDVGUU80T0Zud3dqTXBkcklKd0VhQ1RTUGw5ZXJuUGtqRnJFMTZfZlY1Qkt3YkIzdUdMMTE1c0VvTkxrWUJ2OWNTWVg0ZExlWmw3U0hOeEFDWTFIdHRv?oc=5", "source_name": "scanx.trade", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Q3 net profit, revenue up but margins falter; declares \u20b92 interim dividend", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Limited Schedules Board Meeting for February 3, 2026 to Review Q3FY26 Results and Consider Interim Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdWlIQWZTLWF5UUJ4X0FjaWF5V3RlLUNzemVzOTRYUHVtQzhQTDZqSUt6Rm52dndLVzdneEhDeFpsQy14YkloUEJScy1SZlBXcXBDRGVUZTMzZk5ibU53M2FuOExidm1yeFlJc2d3T1Z3ekFGUGRydTZZYjF6Z0RVd01qdHZ6bW1uT2tfNkw4UVpLc1JfSDdURHNfSW5kaWc0d01kOEVGYWhUSVcybXF4b0ltVWdVcHhQUS1CblV1YWs0MzhoYkQtRUZKMHB1QktmaTdxQ1JHeVFjSmxpOThMT3NMWTYtcFUyMXoza0h5VTZEcGtONk80S2ZlTVhtRkRPcVA1MQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Ltd. Share Price Today - Aarti Drugs Ltd. Stock Price Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE9wMW5ORF9jT2tTVXgzaWNsaDNHemxINmpGYmVyZktxR1Qxc2lvS2xxdTNtdWRDSjVBQndoU2gyU01NaUVReG10amxORGpWLXFDMTRiV1J1aDJSV1R2d0o2OFhNV1p5a3JvcTluTDFrdXh0dlRHYVZOVEV3?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-02T10:51:34+00:00", "published_display": "02 Jan 2026 10:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Don't See Light At End Of Aarti Drugs Limited's (NSE:AARTIDRUGS) Tunnel And Push Stock Down 25%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-11T08:00:00+00:00", "published_display": "11 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Reports 9% Revenue Growth to \u20b9653Cr with Improved Margins in Q2FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOV2FHdjJ0UEJQOEJETkF1Q1BBdU1aenNqN0N3dkVjZEtkWXcweXU3OW1tX1pkdzNrS3BBSlZWQ0hud3RCdkZreWNiZHpwZFVsSkVEVVlaS2RFb2FpTVoxaW9UXzYzNUFuYW8wWGZEVlNUeFRpb0dHc0syUXdGa2RGdExkNjUxTXJDOEhsT29VazVnV2tWZDk4Ynl3bXlnRXJHdDF5UTNIbThMNHNUOHo2NkZVUjNYVTNxYmNfTDUwYS1kcHFfV1l4SXlB?oc=5", "source_name": "scanx.trade", "published_at": "2025-11-07T08:00:00+00:00", "published_display": "07 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs (NSE:AARTIDRUGS) Has A Pretty Healthy Balance Sheet", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-08-06T07:00:00+00:00", "published_display": "06 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Buy Aarti Drugs Ltd For Target Rs.610 Axis Securities Ltd", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQSm9IQlNNNjFncWZtaTV3SS1MMW5ITXpnY2NtcUZycDdmcHZqWTJpek10VFBhZ2daZEY4SVVpV2FOQm00TWlBS2VFRGxuZ091X1JhcnItWktfcXhVYlVaZUFZQy1rS0ZLa3pPek5uTWNkRDVqcHg3czYwZmdmZUNXSm9PRTZ0S0FrOGdmZEN5bnZqUzlNX3NLZ09fNHRvbGFoWmxWNHFBLURRQQ?oc=5", "source_name": "Investment Guru India", "published_at": "2025-07-24T07:00:00+00:00", "published_display": "24 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Prakash Patil Aarti Drugs Limited's (NSE:AARTIDRUGS) CEO is the most bullish insider, and their stock value gained 12%last week", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-16T07:00:00+00:00", "published_display": "16 Jul 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4FY25 earnings impact: Aarti Drugs shares up 14% on profit growth, MGL and KEI shares higher up to 4%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2025-05-07T07:00:00+00:00", "published_display": "07 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aarti Drugs Ltd. Share Price Today | Aarti Drugs Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE1sclltb2Q5aXYyNVJOam1uODZVeHFtNnUtRExtY042a1JFSlFrRnJHYjhDWi0xSDBYZWRhYndDYnJDMG1WZ2w3TVpfWjRHUi1KUkt2OXdlSDg5XzE5aVlLZVNZQXBJU2lVTTJaNTFCekhlVmc?oc=5", "source_name": "Value Research", "published_at": "2022-03-25T11:02:47+00:00", "published_display": "25 Mar 2022 11:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 18, "sentiment_summary": {"positive": 7, "negative": 0, "neutral": 11, "score": 59, "total": 18, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 5.3, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 3.45, "count": 5}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 396.8, "latest_week": "2026-07-10", "one_week_move": 2.6, "four_week_move": 6.8, "twelve_week_move": 6.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.360441, "market_dynamics_buy_signal": false, "relative_strength": -2.713773, "fair_value_gap": -13.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.3528, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.6% over one week, +6.8% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 68, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "scanx.trade", "count": 9}, {"label": "simplywall.st", "count": 4}, {"label": "CNBC TV18", "count": 2}, {"label": "Investment Guru India", "count": 1}, {"label": "Moneycontrol.com", "count": 1}, {"label": "Value Research", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Earnings", "count": 5}, {"label": "Analyst action", "count": 3}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.6% over one week, +6.8% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Aarti Drugs promoter group encumbers 12.39 lakh shares"}], "updated_at": "2026-07-17T18:37:36.278666+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}